From: A population-based analysis of immunosuppression therapy after organ transplantation
Bavaria, outpatients | Nationwide, in- and outpatients | |||||
---|---|---|---|---|---|---|
N (%) | €/patient | Total costs | N (%) | €/patient | Total costs | |
Glucocorticoids | 7,467 (72.6%) | 140 | 1,046,673 | 9,266 (78.7%) | 170 | 1,577,736 |
Prednisolone | 6,357 (61.8%) | 116 | 739,781 | 6,922 (58.8%) | 132 | 916,067 |
Prednisone | 1,158 (11.3%) | 84 | 96,987 | 1,926 (16.3%) | 108 | 208,750 |
Methylprednisolone | 389 (3.8%) | 159 | 62,010 | 1,328 (11.3%) | 216 | 287,455 |
Dexamethasone | 879 (8.5%) | 168 | 147,404 | 1,057 (9.0%) | 157 | 165,423 |
Cloprednol | 1 (0.0%) | 492 | 492 | 2 (0.0%) | 20 | 41 |
Mycophenolic Acid | 6,630 (64.5%) | 7,883 | 52,266,731 | 6,919 (58.7%) | 7,405 | 51,234,611 |
mTOR inhibitors | 1,454 (14.1%) | 26,808 | 38,979,315 | 1,834 (15.6%) | 26,796 | 49,143,000 |
Everolimus | 895 (8.7%) | 33,971 | 30,403,614 | 1,321 (11.2%) | 31,946 | 42,200,100 |
Sirolimus | 586 (5.7%) | 14,634 | 8,575,701 | 536 (4.5%) | 12,953 | 6,942,900 |
Calcineurin Inhibitors | 8,251 (80.2%) | 17,850 | 147,282,666 | 9,221 (78.3%) | 17,015 | 156,893,530 |
Tacrolimus | 6,324 (61.5%) | 21,224 | 134,218,122 | 6,259 (53.1%) | 22,228 | 139,127,575 |
Ciclosporin | 2,233 (21.7%) | 5,851 | 13,064,544 | 3,359 (28.5%) | 5,289 | 17,765,956 |
Azathioprine | 546 (5.3%) | 572 | 312,414 | 586 (5.0%) | 562 | 329,254 |
Belatacept | 80 (0.8%) | 36,886 | 2,950,917 | 170 (1.4%) | 29,356 | 4,990,483 |